comparemela.com

Latest Breaking News On - Anti vegf - Page 4 : comparemela.com

Applying CATT Study Results in Real World

Experts discuss the comparison of age-related macular degeneration treatments trials (CATT) and how today’s retina specialists can apply the results in their daily practice.

Anti vegfAge related macular degenerationMacular degenerationDiabetic macular edemaSuboptimal response

Eyes On The Prize: The Latest Developments in Retinal Gene Therapies

This article will discuss some of the most promising gene therapies for age-related macular degeneration, including ADVM-022, RGX-314, GT-005, and HMR59.

Retinal geneAdverum biotechnologiesAnti vegfVision lossRegenerative medicineRetinal gene therapyGene therapyRetinal diseasesMacular degeneration

Real-World Long-Term Safety Data of Anti-VEGF Agents

Experts discuss safety data of anti-vascular endothelial growth factor (Anti-VEGF) agents while highlighting the importance of sharing this information with patients and relevant care providers.

World long term safety dataAge related macular degenerationAnti vegfMacular degenerationDiabetic macular edemaSystemic side effectsRecent event

MyJournals org - Science - Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema (BMC Ophthalmology)

MyJournals.org - Science - Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema (BMC Ophthalmology)

Ced hfvAnti vegf

Bevacizumab First-line Treatment More Cost-Effective in RVO vs Aflibercept

Aflibercept was a less cost-effective treatment for retinal vein occlusion (RVO) compared with bevacizumab, although visual acuity outcomes were similar.

Early treatment diabetic retinopathy studyMacular edemaAnti vegfScore2 trial

vimarsana © 2020. All Rights Reserved.